School of Medicine
Showing 6,801-6,850 of 13,027 Results
-
Norman Lowenbraun
Member, Cardiovascular Institute
BioDr Lowenbraun has been a practicing cardiologist in the Bay Area for over 25 years, having moved here after receiving his medical and specialty training on the East Coast. He believes offering the personal care of a community setting and empowering the patient in their healthcare decisions, combined with the resources of Stanford Hospital , offers his patients the best of both worlds.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Lu,Guolan
Assistant Professor of Urology
Current Research and Scholarly InterestsThe Lu Lab develops and integrates AI, spatial multi-omics, and advanced imaging to understand and model how cells, tissues, and therapeutic agents interact in their native spatial context, and how these interactions drive disease progression and treatment response.
-
Janice Lu
Clinical Professor, Medicine - Oncology
BioDr. Janice Lu is Clinical Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine. She specializes in the treatment of breast cancer, with expertise in hormone receptor–positive and HER2-positive disease, antibody-drug conjugates, and immunotherapy. Dr. Lu has led and contributed to multiple clinical trials, including playing a key role in the EMERALD trial, which resulted in FDA approval of the first oral SERD for ESR1-mutated ER+/HER2- metastatic breast cancer. Her translational research focuses on liquid biopsy, epigenetics, AI and multiomics approaches to treatment resistance. She has chaired national sessions on precision oncology and holds leadership roles with NRG Oncology and ASCO, including Vice-Chair of the NRG Immunotherapy Subcommittee and Track Leader for ASCO’s Developmental Therapeutics and Targeted Therapy Education Program. She has also served on committees for the National Comprehensive Cancer Network (NCCN) and the Southwest Oncology Group (SWOG).
Dr. Lu completed her Hematology and Oncology fellowship at New York University School of Medicine and earned a PhD in epigenetics under the mentorship of late Dr. David Allis, a pioneer in the field and 2018 Lasker Laureate. Prior to joining Stanford, she was Director of Breast Medical Oncology and led the Circulating Tumor Cell (CTC) Core Lab at Northwestern University Feinberg School of Medicine, before returning to the Bay Area to be with her family and to further expand research and patient-centered care. -
Junjie Lu
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioJunjie's research is centered on the social determinants of minority health, epidemiological methods, and clinical effectiveness. He is deeply committed to understanding the health disparities faced by minority populations. His clinical background helps bridge the gap between research and practical application, aiming to improve healthcare outcomes in real-world settings.
Junjie Lu earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, where he concentrated on Health and Social Behavior. He also holds an MBBS and an MS from Shanghai University of Traditional Chinese Medicine. Junjie gained practical experience as an intern doctor at a university hospital for two years, during which he led a pilot randomized controlled trial on the effects of acupuncture on depressive symptoms. -
Sydney X. Lu
Assistant Professor of Medicine (Hematology)
BioSydney Lu is an assistant professor and physician-scientist in the Division of Hematology, Department of Medicine with a broad interest in both normal and abnormal RNA processing in the context of normal physiology and disease states. The laboratory studies translational questions regarding the mechanistic basis of RNA processing abnormalities in malignant blood disorders, their implications for leukemogenesis and cancer biology, as well as resultant therapeutic opportunities.
As a physician, Sydney’s group is particularly focused on dissecting RNA processing abnormalities in primary patient samples and disease-relevant preclinical model systems. Lab members employ a variety of ‘wet-lab’ and computational approaches to study transcriptome abnormalities in (1) states of immune dysfunction, (2) myeloid blood cancers such as myelodysplastic syndromes and acute myeloid leukemia, and (3) lymphoid blood cancers such as chronic lymphocytic leukemia. Additional projects are focused on novel therapeutics, including multiple targeted agents which modulate RNA processing, for the selective treatment of these diseases.
Sydney’s research is/has been supposed by grant funding from the National Cancer Institute, Parker Institute for Cancer Immunotherapy, Leukemia & Lymphoma Society, Aplastic Anemia & Myelodysplastic Syndromes International Foundation, the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the Paula and Rodger Riney Foundation, the Doris Duke Charitable Foundation, The Gabrielles Angel Foundation for Cancer Research, and the Stanford Cancer Institute. -
Wan-Jin Lu
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioDr. Wan-Jin Lu is a Research Scientist in Dr. Phil Beachy's lab. Wan-Jin grew up in Taiwan, obtained her B.S. in Zoology at National Taiwan University and completed her PhD in Genetics and Development at UT Southwestern in the lab of Dr. John Abrams. Her Ph.D. research involved the identification of the evolutionary conserved function of the tumor suppressor gene p53 that ensures the quality control of germ cells. She then moved to the Bay Area, where she was a Damon Runyon Postdoctoral Fellow in the Institute of Stem Cell Biology and Regenerative Medicine in the Beachy lab. Her work currently focuses on understanding the function of Hedgehog signaling in taste receptor cell homeostasis and delineating the mechanisms of taste receptor regeneration after chemotherapy-induced loss.
Since 2017, she has been collaborating with Tabula Muris And Tabula Sapiens Consortium to investigate taste receptor stem cell renewal and regeneration in the Beachy lab. Her work has received funding support from California Institute of Regenerative Medicine (CIRM), Thomas and Stacey Siebel Foundation, and NIH (R21 and R01). -
Ying Lu
Professor of Biomedical Data Science and, by courtesy, of Epidemiology
Current Research and Scholarly InterestsBiostatistics, clinical trials, statistical evaluation of medical diagnostic tests, radiology, osteoporosis, meta-analysis, medical decision making
-
Anna Luan, MD, MS
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Luan is a fellowship-trained plastic and reconstructive surgeon and hand and upper extremity surgeon with Stanford Health Care. She is a clinical assistant professor in the Department of Surgery, Division of Plastic & Reconstructive Surgery at Stanford University School of Medicine.
Dr. Luan specializes in diagnosing and treating hand and peripheral nerve disorders. She treats issues such as fractures, instability, soft tissue injuries, degenerative conditions, spasticity, nerve compression, and peripheral nerve injuries. She also treats many other conditions that cause pain or other problems with the hands.
In addition, Dr. Luan has expertise in treating patients with upper and lower extremity amputations. Amputations can result from trauma, tumors, vascular disease, or infection. Dr. Luan specializes in surgeries to help prevent or treat pain and to maximize function in upper and lower extremity amputations. She takes a personalized approach to patient care, considering each individual’s condition, concerns, and goals.
Dr. Luan’s research interests include innovation and translational research, which applies the results of scientific research to treating patients or preventing illness. She also researches clinical outcomes and global surgery. Additionally, Dr. Luan’s research explores how technologies such as artificial intelligence (AI), machine learning, and deep learning can be used to improve patient care.
Dr. Luan has published in many peer-reviewed journals, including the Journal of Hand Surgery and Plastic and Reconstructive Surgery. She also serves as a reviewer for multiple journals. She has authored textbook chapters and delivered presentations at symposiums and conferences nationally and worldwide.
Dr. Luan is an affiliated faculty member of the Stanford Center for Artificial Intelligence in Medicine and Imaging. The center focuses on responsible innovation and research in medical AI applications. She is also a member of the American Society of Plastic Surgeons, American Association for Hand Surgery, American Society for Surgery of the Hand, and California Society of Plastic Surgeons. -
Anniek Frederike Lubberding
Affiliate, Pediatrics - Endocrinology
BioHuman biologist and (electro-)physiologist bridging cardiac and pancreatic research to improve treatment of diabetes and heart disease.
-
Stephen Luby
Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting environmental pathways of disease in low- and middle-income countries.
-
Anthony R. Lucas
Postdoctoral Scholar, Psychiatry
BioAnthony R. Lucas, PsyD is a postdoctoral fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He provides psychotherapy in the ADAPT Clinic for Mood and Anxiety Disorders and the Addiction Medicine Dual Diagnosis Clinic.
In the ADAPT Clinic, Dr. Lucas focuses on diagnostic formulation and psychotherapy for mood and anxiety disorders, drawing on structured and transdiagnostic approaches while attending to the psychological and contextual factors that shape symptom presentation and recovery.
In the Addiction Medicine Dual Diagnosis Clinic, he provides psychotherapy for individuals with substance use disorders and behavioral addictions and co-occurring psychiatric conditions, centering collaborative treatment planning and addressing the interplay between addiction, trauma, and mental health.
Dr. Lucas also provides clinical supervision to graduate student trainees at the Palo Alto VA, with a focus on case formulation, clinical reasoning, and reflective professional development.
Dr. Lucas completed his APA-accredited doctoral internship in Clinical Psychology at Kaiser Permanente Northern California, Addiction Medicine & Recovery Services, Walnut Creek. -
Kristine Luce
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Luce is a Psychologist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. She received her doctorate in Clinical Psychology from Kent State University. She completed a pre-doctoral internship at the Seattle Veterans Hospital and a post-doctoral research fellowship at Stanford University in the Department of Psychiatry and Behavioral Sciences. Dr. Luce has clinical and research experience with eating-related disorders and is the Co-Director of the Stanford Adult Eating Disorders Program. In addition, Dr. Luce treats anxiety and mood disorders and has specialized clinical training in Cognitive Behavioral Therapy and Dialectical Behavioral Therapy.
-
Linda Lucian
Sr. Manager, Translational Programs, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordPrimary Biodesign role of Translation Project Manager for the eight internal funding programs administered through Biodesign. Stanford- Coulter TRPP Award, NIH funded Spectrum-Medtech Award, Wu Tsai Neuroscience:Translate Award, Innovation Fellowship Extension Award, Innovation Course Extension Award, Faculty Fellowship Award, NEXT Award, and Robert Howard Next Step Award.
-
Chase A. Ludwig, MD, MS
Assistant Professor of Ophthalmology (Research/Clinical Trials)
Current Research and Scholarly InterestsMy research focuses on understanding high and pathologic myopia and their retinal sequelae, including retinal detachments, myopic traction maculopathy, and myopic macular degeneration. By leveraging informatics and big data analytics, I aim to uncover strategies that prevent and treat the progression of these complex and devastating conditions. My work takes advantage of the retina’s unique role as the only visible portion of the central nervous system, allowing for discoveries in ophthalmology that have the potential to impact broader fields of medicine.
I am actively seeking medical students and residents interested in ophthalmology or vitreoretinal surgery to assist with writing projects and data analytics. If you are passionate about advancing the understanding and management of myopia, I invite you to join me in tackling one of the most pressing global challenges in eye care. -
Charlotte Luff
Postdoctoral Scholar, Psychiatry
BioCharlotte is a postdoctoral scholar in the lab of Professor Luis de Lecea. Her research interests include the brain phenomena underpinning non-invasive neuromodulation such as focused ultrasound and electrical brain stimulation, and in the de Lecea lab she studies this with relation to sleep and addiction. Charlotte completed her PhD in the Interventional Systems Neuroscience lab of Dr Nir Grossman at Imperial College London. Her PhD research focused on uncovering the biophysical mechanism of temporal interference (TI) brain stimulation, primarily using electrophysiology and computational modelling. During her PhD, Charlotte spent a year as a visiting PhD student in Professor Ed Boyden’s lab at MIT, where she was trained in automated in-vivo patch clamp. Previously, Charlotte completed a BSc in Biomedical Science at King’s College London, and an MRes in Experimental Neuroscience at Imperial College London.
-
George Lui
Clinical Professor, Medicine - Cardiovascular Medicine
Clinical Professor, Pediatrics - CardiologyCurrent Research and Scholarly InterestsAdult Congenital Heart Disease
-
Natalie Shaubie Lui
Assistant Professor of Cardiothoracic Surgery (Thoracic Surgery)
BioDr. Lui studied physics as an undergraduate at Harvard before attending medical school at Johns Hopkins. She completed a general surgery residency at the University of California San Francisco, which included two years of research in the UCSF Thoracic Oncology Laboratory and completion of a Master in Advanced Studies in clinical research. Dr. Lui went on to hold a fellowship in Thoracic Surgery at Massachusetts General Hospital, during which she participated in visiting rotations at Memorial Sloan Kettering and the Mayo Clinic.
Dr. Lui’s surgical practice consists of general thoracic surgery with a focus on thoracic oncology and robotic thoracic surgery. Her research interests include intraoperative molecular imaging for lung cancer localization, increasing rates of lung cancer screening, and using artificial intelligence to predict lung cancer recurrence. She is the recipient of the Donald B. Doty Educational Award in 2019 from the Western Thoracic Surgical Association, the Dwight C. McGoon Award for teaching from the Thoracic Surgery Residents Association in 2020, and the Carolyn E. Reed Traveling Fellowship from the Thoracic Surgery Foundation and Women in Thoracic Surgery in 2022.
